Women and vulnerability to HAART non-adherence: A literature review of treatment adherence by gender from 2000 to 2011

Current HIV/AIDS Reports

Volumn 8, Issue 4, 2011, Pages 277-287

  Puskas, Cathy M ^b   Forrest, Jamie I ^a   Parashar, Surita ^a   Salters, Kate A ^a   Cescon, Angela M ^a   Kaida, Angela ^b   Miller, Cari L ^b   Bangsberg, David R ^c,d   Hogg, Robert S ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Antiretroviral therapy; Gender; HIV; Patient compliance

Indexed keywords

DEVELOPED COUNTRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MEDICAL LITERATURE; PREVALENCE; REVIEW; SEX DIFFERENCE; TREATMENT REFUSAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DEVELOPED COUNTRIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; SEX FACTORS;

EID: 81355127432     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-011-0098-0     Document Type: Review

References (93)

1. DL Paterson S Swindells J Mohr, et al. 2000 Adherence to protease inhibitor therapy and outcomes in patients with HIV infection Ann Intern Med 133 21 30 10877736 1:STN:280:DC%2BD3czit1altA%3D%3D (Pubitemid 30432540)
2. F Maggiolo M Airoldi HD Kleinloog, et al. 2007 Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients HIV Clin Trials 8 282 92 17956829 10.1310/hct0805-282 (Pubitemid 350099562)
3. P Roux MP Carrieri J Cohen, et al. 2009 Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment Clin Infect Dis 49 1433 40 19807275 10.1086/630209
4. A Palepu MW Tyndall R Joy, et al. 2006 Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy Drug Alcohol Depend 84 188 94 16542797 10.1016/j.drugalcdep.2006.02.003 (Pubitemid 44119095)
5. PS Sullivan ML Campsmith GV Nakamura, et al. 2007 Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy PLoS One 6 e552 10.1371/journal.pone.0000552 (Pubitemid 351194007)
6. JT Parsons E Rosof B Mustanski 2007 Patient-related factors predicting HIV medication adherence among men and women with alcohol problems J Health Psychol 12 357 70 17284499 10.1177/1359105307074298 (Pubitemid 46198589)
7. MK McDonnell Holstad JC Pace K Anindya, et al. 2006 Factors associated with adherence to antiretroviral therapy J Assoc Nurses AIDS Care 17 4 15 10.1016/j.jana.2006.01.002 (Pubitemid 43562445)
8. LM Kuyper E Wood JSG Montaner, et al. 2004 Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort J Acquir Immune Defic Syndr 37 1470 6 15602125 10.1097/01.qai.0000138379.39317.62 (Pubitemid 39602337)
9. D Kacanek DL Jacobson D Spiegelman, et al. 2010 Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the nutrition for healthy living study J Acquir Immune Defic Syndr 53 266 72 20104122 10.1097/QAI.0b013e3181b720e7 This study showed a significant relationship between incident depression and suboptimal ART adherence. A significantly higher proportion of women than men developed depressive symptoms and were less likely to be adherent.
10. V Kumar W Encinosa 2009 Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients Psychiatr Q 80 131 41 19387832 10.1007/s11126-009-9100-z
11. VD Lima J Geller DR Bangsberg, et al. 2007 The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART AIDS 21 1175 83 17502728 10.1097/QAD. 0b013e32811ebf57 (Pubitemid 46763288)
12. + counts in people living with HIV AIDS Patient Care STDS 19 728 36 16283833 10.1089/apc.2005.19.728 (Pubitemid 41705169)
13. KD Phillips L Moneyham C Murdaugh, et al. 2005 Sleep disturbance and depression as barriers to adherence Clin Nurs Res 14 273 93 15995155 10.1177/1054773805275122 (Pubitemid 41129331)
14. A Ammassari A Antinori MS Aloisi, et al. 2004 Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons Psychosomatics 45 394 402 15345784 10.1176/appi.psy.45.5.394 (Pubitemid 39166911)
15. JS Gonzalez FJ Penedo MH Antoni, et al. 2004 Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS Health Psychol 23 413 8 15264978 10.1037/0278-6133.23.4.413 (Pubitemid 38880174)
16. SJ Fielden MLA Rusch B Yip, et al. 2008 Nonadherence increases the risk of hospitalization among HIV-infected antiretroviral naïve patients started on HAART J Int Assoc Physicians AIDS Care 7 238 44 10.1177/1545109708323132
17. A Ubbiali D Donati C Chiorri, et al. 2008 Prediction of adherence to antiretroviral therapy: can patients' gender play some role? An Italian pilot study AIDS Care 20 571 5 18484327 10.1080/09540120701867172 1:STN:280: DC%2BD1czit12gsQ%3D%3D This study examines the psychological characteristics of both non-adherent and adherent men and women, with a focus on relational style. Differences between genders were observed, with non-adherent women having a greater preoccupation with relationships and need for approval, while non-adherent men were found to be less relationship-oriented
18. JN Sayles MD Wong JJ Kinsler, et al. 2009 The association of stigma with self-reported access to medical care and antiretroviral therapy adherence in persons living with HIV/AIDS J Gen Intern Med 24 1101 8 19653047 10.1007/s11606-009-1068-8
19. LS Rintamaki TC Davic S Skripkauskas, et al. 2006 Social stigma concerns and HIV medication adherence AIDS Patient Care STDS 20 359 68 16706710 10.1089/apc.2006.20.359 (Pubitemid 43800964)
20. J Leserman G Ironson C O'Cleirigh, et al. 2008 Stressful life events and adherence to HIV AIDS Patient Care STDS 22 403 11 18373416 10.1089/apc.2007.0175 (Pubitemid 351733239)
21. SA Wood C Tobias J McCree 2004 Medication adherence for HIV positive women caring for children: in their own words AIDS Care 16 909 13 15385246 10.1080/09540120412331290158 1:STN:280:DC%2BD2cvnsVajsg%3D%3D (Pubitemid 39331679)
22. MJ Mugavero JL Raper S Reif, et al. 2009 Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study Psychosom Med 9 920 6 10.1097/PSY.0b013e3181bfe8d2
23. S Shin M Muñoz B Espiritu, et al. 2008 Psychosocial impact of poverty on antiretroviral nonadherence among HIV-TB coinfected patients in Lima, Peru J Int Assoc Physicians AIDS Care 7 74 81 10.1177/1545109708315326
24. AR Knowlton JH Arnsten LJ Eldred, et al. 2010 Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors AIDS Patient Care STDS 24 421 8 20578910 10.1089/apc.2009. 0240
25. JJ Pulvirenti R Glowacki U Muppiddi, et al. 2003 Hospitalized HIV-infected patients in the HAART era: a view from the inner city AIDS Patient Care STDS 17 565 73 14746664 10.1089/108729103322555953 (Pubitemid 37444833)
26. DM Moore W Zhang M Genebat, et al. 2010 Non-medically supervised treatment interruptions among participants in a universally accessible antiretroviral therapy programme HIV Med 11 299 307 20002777 10.1111/j.1468-1293.2009.00779.x 1:CAS:528:DC%2BC3cXmslCnsLk%3D
27. ER Carmody T Diaz P Starling, et al. 2003 An evaluation of antiretroviral HIV/AIDS treatment in a Rio de Janeiro public clinic Trop Med Int Health 8 378 85 12753630 10.1046/j.1365-3156.2003.01046.x (Pubitemid 36733586)
28. Y Yuan G L'Italien J Mukherjee, et al. 2006 Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort HIV Med 7 156 62 16494629 10.1111/j.1468-1293.2006. 00355.x 1:STN:280:DC%2BD287gvVKjtw%3D%3D (Pubitemid 43337594)
29. VD Lima DR Bangsberg PR Harrigan, et al. 2010 Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level J Acquir Immune Defic Syndr 55 460 5 20838225 10.1097/QAI.0b013e3181f2ac87 1:CAS:528:DC%2BC3cXhtl2ltLzN
30. MA Jhaveri SR Browning H Bush, et al. 2009 Comparison of 3-drug versus 4 drug and PI versus non-PI combinations as initial HAART: experience from 1998 to 2007 J Int Assoc Physicians AIDS Care 8 299 307 10.1177/1545109709345666
31. BJ Turner C Laine L Cosler, et al. 2003 Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users J Gen Intern Med 18 248 57 12709091 10.1046/j.1525-1497. 2003.20122.x (Pubitemid 36529041)
32. AJ Applebaum MA Richardson SM Brady, et al. 2009 Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder AIDS Behav 13 60 5 18690532 10.1007/s10461-008-9441-x
33. L Sherr F Lampe S Norwood, et al. 2007 Successive switching of antiretroviral therapy is associated with high psychological and physical burden Int J STD AIDS 18 700 4 17945049 10.1258/095646207782193821 (Pubitemid 351738902)
34. E Wood RS Hogg B Yip, et al. 2006 Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts ≥200 cells/μl AIDS 20 1117 23 16691062 10.1097/01.aids.0000226951.49353.ed (Pubitemid 43786099)
35. TS Barfod J Gerstoft L Rodkjaer, et al. 2005 Patients' answers to simple questions about treatment satisfaction and adherence and depression are associated with failure of HAART: a cross-sectional survey AIDS Patient Care STDS 19 317 25 15916494 10.1089/apc.2005.19.317 (Pubitemid 40770655)
36. MP Carrieri F Raffi C Lewden, et al. 2003 Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study Antivir Ther 8 585 94 14760892 1:CAS:528:DC%2BD2cXivVSqu7w%3D (Pubitemid 38057104)
37. B Roca CJ Gómez A Arnedo 2000 A randomized, comparative study of lamivudine plus stavudine, with indinavir or nelfinavir in treatment-experienced HIV-infected patients AIDS 14 157 61 10708286 10.1097/00002030-200001280-00011 1:CAS:528:DC%2BD3cXhvFWmsLk%3D (Pubitemid 30116441)
38. JM Simoni DW Pantalone MD Plummer B Huang 2007 A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women Health Psychol 26 488 95 17605569 10.1037/0278-6133.26.4.488 (Pubitemid 47445006)
39. RH Remien FI Bastos V Terto Jr, et al. 2007 Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil AIDS Care 19 740 8 17573593 10.1080/09540120600842516 1:STN:280:DC%2BD2szlvFKgsQ%3D%3D (Pubitemid 46944271)
40. MO Johnson E Charlebois SF Morin, et al. 2005 Perceived adverse effects of antiretroviral therapy J Pain Symptom Manage 29 193 205 15793937 10.1016/j.jpainsymman.2004.05.005 (Pubitemid 40279056)
41. A-D Bouhnik M Chesney P Carrieri, et al. 2002 Nonadherence among HIV-infected injecting drug users: the impact of social instability J Acquir Immune Defic Syndr 31 S149 53 12562040 10.1097/00126334-200212153-00013
42. L Sherr FC Lampe C Clucas, et al. 2010 Self-reported non-adherence to ART and virological outcome in a multiclinic UK study AIDS Care 22 939 45 20574863 10.1080/09540121.2010.482126 1:STN:280:DC%2BC3cjhsFKmuw%3D%3D
43. J Montaner 2011 Treatment as prevention-a double hat-trick Lancet 378 208 9 21763923 10.1016/S0140-6736(11)60821-0
44. T Kerr J Walsh E Lloyd-Smith E Wood 2005 Measuring adherence to highly active antiretroviral therapy: implications for research and practice Curr HIV/AIDS Rep 2 200 5 16343379 10.1007/s11904-005-0017-3
45. United Nations Development Program: Human development index and its components. Available at http://hdr.undp.org/en/statistics/. Accessed May 2011.
46. M Kyser K Buchacz TJ Bush, et al. 2011 Factors associated with non-adherence to antiretroviral therapy in the SUN study AIDS Care 23 601 11 21293992 10.1080/09540121.2010.525603
47. SW Royal DP Kidder S Patrabansh, et al. 2009 Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV AIDS Care 21 448 55 19401865 10.1080/09540120802270250
48. MJ Miguez-Burbano L Espinoza JE Lewis 2008 HIV treatment adherence and sexual functioning AIDS Behav 12 78 85 17295075 10.1007/s10461-006-9197-0 (Pubitemid 351143445)
49. L Sherr F Lampe S Norwood, et al. 2008 Adherence to antiretroviral treatment in patients with HIV in the UK: a study of complexity AIDS Care 20 442 8 18449821 10.1080/09540120701867032 (Pubitemid 351652487)
50. MC Beach PS Duggan RD Moore 2007 Is patients' preferred involvement in health decisions related to outcomes for patients with HIV? J Gen Intern Med 22 1119 24 17514382 10.1007/s11606-007-0241-1 (Pubitemid 47038054)
51. P Peretti-Watel B Spire F Lert, et al. 2006 Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003) Drug Alcohol Depend 82 S71 9 16769450 10.1016/S0376-8716(06)80012-8 (Pubitemid 43850179)
52. P Peretti-Watel B Spire MA Schiltz, et al. 2006 Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients Soc Sci Med 62 2420 33 16289743 10.1016/j.socscimed.2005.10.020 1:STN:280:DC%2BD287mtlKntw%3D%3D
53. JA Cook D Grey J Burke, et al. 2004 Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women Am J Public Health 94 1133 40 15226133 10.2105/AJPH.94.7.1133 (Pubitemid 38857313)
54. M Deloria-Knoll JS Chmiel AC Moorman, et al. 2004 Factors related to and consequences of adherence to antiretroviral therapy in an ambulatory HIV-infected patient cohort AIDS Patient Care STDS 18 721 7 15659883 10.1089/apc.2004.18.721 (Pubitemid 40066164)
55. CA Kleeberger J Buechner F Palella, et al. 2004 Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study AIDS 18 683 8 15090774 10.1097/00002030-200403050-00013 (Pubitemid 38393468)
56. A Palepu MW Tyndall K Chan, et al. 2004 Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes Antivir Ther 9 713 9 15535408 (Pubitemid 39434334)
57. TT Sharpe LM Lee AK Nakashima, et al. 2004 Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women J Community Health 29 117 27 15065731 10.1023/B:JOHE.0000016716.99847.9b (Pubitemid 39012830)
58. OW Fong CF Ho LY Fung, et al. 2003 Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients HIV Med 4 133 8 12702134 10.1046/j.1468-1293.2003.00147.x 1:STN:280:DC%2BD3s7otlOjuw%3D%3D (Pubitemid 36582296)
59. B Spire S Duran M Souville, et al. 2002 Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach Soc Sci Med 54 1481 96 12061483 10.1016/S0277-9536(01)00125-3 (Pubitemid 34309013)
60. GJ Wagner RH Remien A Carballo-Diéguez C Dolezal 2002 Correlates of adherence to combination antiretroviral therapy among members of HIV-positive mixed status couples AIDS Care 14 105 9 11798409 10.1080/09540120220097973 1:STN:280:DC%2BD38%2Fnt1alsw%3D%3D (Pubitemid 34095170)
61. LFM Brigido R Rodrigues J Casseb, et al. 2001 Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil AIDS Patient Care STDS 15 587 93 11788069 10.1089/108729101753287685 1:STN:280:DC%2BD38%2FmtFCltw%3D%3D (Pubitemid 33139486)
62. S Duran B Spire F Raffi, et al. 2001 Self-reported symptoms after initiation of a protease inhibitor on HIV-infected patients and their impact on adherence to HAART HIV Clin Trials 2 38 45 11590513 10.1310/R8M7-EQ0M-CNPW-39FC 1:STN:280:DC%2BD3MrktlOjuw%3D%3D (Pubitemid 32181748)
63. R Gross B Yip LR Re, et al. 2006 A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression J Infect Dis 15 1108 14 10.1086/507680 (Pubitemid 44547650)
64. M Plankey P Bacchetti J Chengshi, et al. 2009 Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study AIDS Behav 13 53 9 18688706 10.1007/s10461-008-9444-7
65. CR Fumaz JA Muñoz-Moreno J Moltó, et al. 2008 Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs AIDS Care 20 796 805 18728987 10.1080/09540120701694022 1:STN:280:DC%2BD1crksF2qtg%3D%3D
66. F Kapadia D Vlahov Y Wu, et al. 2008 Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women Am J Drug Alcohol Abuse 34 161 70 18293232 10.1080/00952990701877052 (Pubitemid 351302169)
67. DJ Merenstein MF Schneider C Cox, et al. 2008 Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study Pediatrics 121 e787 93 18381507 10.1542/peds.2007-1586
68. J Graham IM Bennett WC Holmes R Gross 2007 Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV infected individuals AIDS Behav 11 385 92 17053858 10.1007/s10461-006-9164-9 (Pubitemid 46570813)
69. MJR Vaz SMO Barros R Palacios, et al. 2007 HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women Int J STD AIDS 18 28 32 17326859 10.1258/095646207779949808
70. P Braitstein A Justice DR Bangsberg, et al. 2006 Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort AIDS 20 323 31 16439865 10.1097/01.aids. 0000198091.70325.f4
71. B Södergård M Halvarsson MP Tully, et al. 2006 Adherence to treatment in Swedish HIV-infected patients J Clin Pharm Ther 31 605 15 17176366 10.1111/j.1365-2710.2006.00782.x (Pubitemid 44813773)
72. K Anastos MF Schneider SJ Gange, et al. 2005 The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women J Acquir Immune Defic Syndr 39 537 44 16044004 1:CAS:528:DC%2BD2MXmsV2jtLo%3D (Pubitemid 41098467)
73. PF de Bonolo CC César FA Acúrcio, et al. 2005 Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil AIDS 19 S5 13 10.1097/01.aids.0000191484.84661.2b
74. PN Halkitis AH Kutnick S Slater 2005 The social realities of adherence to protease inhibitor regimens: substance use, health care and psychological states J Health Psychol 10 545 58 16014391 10.1177/1359105305053422 (Pubitemid 41003389)
75. T Kerr A Palepu G Barnes, et al. 2004 Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver Antivir Ther 9 407 14 15259903 (Pubitemid 38878756)
76. H Mohammed L Kieltyka G Richardson-Alston, et al. 2004 Adherence to HAART among HIV-infected persons in rural Louisiana AIDS Patient Care STDS 18 289 96 15186712 10.1089/108729104323076025 (Pubitemid 38720319)
77. A Palepu NJ Horton N Tibbetts, et al. 2004 Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment Addiction 99 361 8 14982549 10.1111/j.1360-0443.2003.00670.x (Pubitemid 38333828)
78. J Delgado KV Heath B Yip, et al. 2003 Highly active antiretroviral therapy: physician experience and enhanced adherence to prescription refill Antivir Ther 8 471 8 14640395 (Pubitemid 37351566)
79. G Parruti L Manzoli PM Toro, et al. 2006 Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse AIDS Patient Care STDS 20 48 57 16426156 10.1089/apc.2006.20.48 1:STN:280:DC%2BD28%2FjvVeiug%3D%3D (Pubitemid 43172782)
80. P García de Olalla H Knobel A Carmona, et al. 2002 Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients J Acquir Immune Defic Syndr 30 105 10 12048370 (Pubitemid 34506694)
81. E Witteveen EJC van Ameijden 2002 Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence Subst Use Misuse 37 1905 25 12511058 10.1081/JA-120016224 (Pubitemid 36076625)
82. J Martín I Escobar R Rubio, et al. 2001 Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIV HIV Clin Trials 2 31 7 11590512 10.1310/0Q8A-DFPR-6RV7-HX10 (Pubitemid 32181747)
83. JP Moatti MP Carrieri B Spire, et al. 2000 Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment AIDS 14 151 5 10708285 10.1097/00002030-200001280-00010 1:STN:280:DC%2BD3c7ntVGkuw%3D%3D (Pubitemid 30116440)
84. JM Duggan A Locher B Fink, et al. 2009 Adherence to antiretroviral therapy: a survey of factors associated with medication usage AIDS Care 21 1141 7 20024773 10.1080/09540120902730039
85. R Cardarelli S Weis E Adams, et al. 2008 General health status and adherence to antiretroviral therapy J Int Assoc Physicians AIDS Care 7 123 9 10.1177/1545109708318526
86. R Garcia R Badaró EM Netto, et al. 2006 Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients AIDS Res Hum Retroviruses 22 1248 52 17209767 10.1089/aid.2006.22.1248 1:CAS:528:DC%2BD2sXis1Gqsg%3D%3D (Pubitemid 46095242)
87. L Moralejo S Inés M Marcos, et al. 2006 Factors influencing adherence to highly active antiretroviral therapy in Spain Curr HIV Res 4 221 7 16611060 10.2174/157016206776055075 1:CAS:528:DC%2BD28XjvFOqtLo%3D
88. J Russell S Krantz S Neville 2004 The patient-provider relationship and adherence to highly active antiretroviral therapy J Assoc Nurses AIDS Care 15 40 7 15358924 10.1177/1055329004269283 (Pubitemid 39360634)
89. NA Haug JL Sorensen ND Lollo, et al. 2005 Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial AIDS Care 17 1022 9 16176898 10.1080/09540120500100882 1:STN:280:DC%2BD2MrgsVWqsg%3D%3D (Pubitemid 41499315)
90. M Sidat C Fairley J Grierson 2007 Experiences and perceptions of patients with 100% adherence to highly active antiretroviral therapy: a qualitative study AIDS Patient Care STDS 21 509 20 17651032 10.1089/apc.2006.0201 (Pubitemid 47221646)
91. NC Ware MA Wyatt T Tugenberg 2006 Social relationships, stigma and adherence to antiretroviral therapy for HIV/AIDS AIDS Care 18 904 10 17012079 10.1080/09540120500330554 1:STN:280:DC%2BD28rotVSlsg%3D%3D (Pubitemid 44521844)
92. PE Stevens E Hildebrandt 2009 Pill taking from the perspective of HIV-infected women who are vulnerable to antiretroviral treatment failure Qual Health Res 19 593 604 19258590 10.1177/1049732309333272
93. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care. 2006;18:140-8. (Pubitemid 41780173)